We are live on ! Find out more
CYAD

Celyad Oncology SA American Depositary Shares
CYAD

Delisted

CYAD was delisted on the 18th of May, 2023.

Back to rankings

7 hedge funds and large institutions have $6.47M invested in Celyad Oncology SA American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 7 → 7 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

26% less capital invested

Capital invested by funds: $8.75M → $6.47M (-$2.28M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$379K
2
Wells Fargo
Wells Fargo
California
-$14.6K
3
Morgan Stanley
Morgan Stanley
New York
-$14.1K
4
UBS Group
UBS Group
Switzerland
-$1.79K
5
Millennium Management
Millennium Management
New York
-$126
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
1
Victory Capital Management
Texas
$6.17M -$379K -44,161 -5%
Morgan Stanley
2
Morgan Stanley
New York
$235K -$14.1K -1,642 -5%
Wells Fargo
3
Wells Fargo
California
$65K -$14.6K -1,704 -17%
UBS Group
4
UBS Group
Switzerland
$4K -$1.79K -209 -29%
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$1K – – –
Millennium Management
6
Millennium Management
New York
– -$126 -12,636 Closed
IA
7
Inspire Advisors
Idaho
– +$454 +53 New

CYAD Hedge Fund Activity: Q4 2020 in Review

7 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q4 2020, worth a combined $6.47M — down 26% from $8.75M a quarter earlier.

Fund positioning in CYAD was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 4 trimmed.

The largest seller was Victory Capital Management, cutting an estimated $379K.

  • 7 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $6.47M of Celyad Oncology SA American Depositary Shares stock for Q4 2020, down 26% quarter-over-quarter.
  • 1 fund opened new Celyad Oncology SA American Depositary Shares positions in Q4 2020 and 1 closed out, a net change of 0 holders.
  • The largest Celyad Oncology SA American Depositary Shares seller in Q4 2020 was Victory Capital Management, an estimated $379K sold.

Based on aggregated 13F filings for Q4 2020.